# bioMérieux

leading the world in clinical microbiology and rapid syndromic testing for infectious diseases.

Source: https://en.bioecon.ru/companies/biomerieux/
Updated: 2026-06-24

- Country: France
- Ticker: BIM.PA

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | Acquired BioFire Diagnostics for $450 million in 2013, funded through indebtedness including new lines of credit | https://www.biospace.com/biomerieux-sa-snags-diagnostics-rival-biofire-diagnostics-inc-for-450-million |
| Capacity | Maintains 19 bio-industrial sites globally, with ongoing investment in capacity expansion, automation, and internalization of production in France and the US | https://www.biomerieux.com/content/dam/biomerieux-com/investor/02---news---reports/2026/en/presentation/FY-2025-Results-Presentation-Investisseurs.pdf, https://www.biomerieux.com/content/dam/biomerieux-com/investor/06---shareholder-area/en/2026/documents-made-available-for-the-shareholders-and-questions-answers/AG-2026---URD-2025.pdf, https://www.biomerieux.com/content/dam/biomerieux-com/investor/regulated-informations/2026/press-releases/PR-bioMerieux-Financial-Results-H1-2026.pdf, https://www.biomerieux.com/content/dam/biomerieux-com/investor/regulated-informations/2026/press-releases/PR_bioMerieux_LaBalme_20260529.pdf |
| Certification | Certified over 250 Class B, C, and D products and 200 Class A devices under IVDR regulation as of 2024; maintains ISO-compliant quality management systems | https://www.biomerieux.com/content/dam/biomerieux-com/investor/02---news---reports/2024/en/annual-report/BIOMERIEUX_ANNUAL-REPORT_2024_EN.pdf, https://www.biomerieux.com/content/dam/biomerieux-com/investor/06---shareholder-area/en/2026/documents-made-available-for-the-shareholders-and-questions-answers/AG-2026---URD-2025.pdf |
| Regulatory approval | Numerous FDA clearances and CE markings for diagnostic platforms (e.g., BIOFIRE, SPOTFIRE, VITEK) | https://www.biomerieux.com/content/dam/biomerieux-com/investor/06---shareholder-area/en/2026/documents-made-available-for-the-shareholders-and-questions-answers/AG-2026---URD-2025.pdf, https://www.biospace.com/biomerieux-sa-snags-diagnostics-rival-biofire-diagnostics-inc-for-450-million, https://www.marketsandmarkets.com/ResearchInsight/rapid-microbiology-testing-market.asp |
| Production site | 19 bio-industrial sites, including facilities in Marcy-l’Étoile and La Balme-les-Grottes, France, and Salt Lake City, USA | https://www.biomerieux.com/content/dam/biomerieux-com/investor/02---news---reports/2024/en/annual-report/BIOMERIEUX_ANNUAL-REPORT_2024_EN.pdf, https://www.biomerieux.com/content/dam/biomerieux-com/investor/06---shareholder-area/en/2026/documents-made-available-for-the-shareholders-and-questions-answers/AG-2026---URD-2025.pdf, https://www.biomerieux.com/content/dam/biomerieux-com/investor/regulated-informations/2026/press-releases/PR_bioMerieux_LaBalme_20260529.pdf, https://www.biomerieux.com/corp/en/journalists/press-releases/biomerieux-invests-in-france-with-a-new-facility-to-produce-innovative-diagnostics.html |
| Headcount | Approximately 15,000 employees as of 2025/2026 | https://www.biomerieux.com/content/dam/biomerieux-com/investor/02---news---reports/2024/en/annual-report/BIOMERIEUX_ANNUAL-REPORT_2024_EN.pdf, https://www.biomerieux.com/content/dam/biomerieux-com/investor/06---shareholder-area/en/2026/documents-made-available-for-the-shareholders-and-questions-answers/AG-2026---URD-2025.pdf |
| Revenue | €4.1 billion in 2025 | https://www.biomerieux.com/content/dam/biomerieux-com/investor/02---news---reports/2026/en/presentation/FY-2025-Results-Presentation-Investisseurs.pdf, https://www.biomerieux.com/content/dam/biomerieux-com/investor/regulated-informations/2026/press-releases/PR_bioMerieux_LaBalme_20260529.pdf |

Independent sources: biospace.com, marketsandmarkets.com

## Technologies

- [Diagnostics & biosensors](https://en.bioecon.ru/technology/diagnostics-biosensors/)
- [Point-of-care molecular diagnostics](https://en.bioecon.ru/technology/point-of-care-molecular-diagnostics/)
- [Sterility testing systems](https://en.bioecon.ru/technology/sterility-testing-systems/)